Pharma Mar | PHM - Sales Revenues

Stock Price
76.55
Daily Change
-0.60 -0.78%
Monthly
-0.26%
Yearly
-16.48%
Q1 Forecast
76.83

Pharma Mar reported EUR35.7M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Almirall EUR 560.46M 71.95M Jun/2025
Avita Medical AUD 18.42M 14K Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 1.02B 878M Sep/2025
Organon & Co USD 1.6B 10M Sep/2025
Pharma Mar EUR 35.7M 20.69M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 190M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025